Forward Pharma A/S
FWPAY · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $48,640 | $56,238 | $51,381 | $43,076 |
| - Cash | $70,770 | $79,087 | $77,598 | $82,542 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$22,130 | -$22,849 | -$26,217 | -$39,466 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6,044 | -$416 | -$6,041 | -$14,992 |
| % Margin | – | – | – | – |
| Net Income | -$1,892 | -$6,449 | -$4,221 | -$8,722 |
| % Margin | – | – | – | – |
| EPS Diluted | -77.41 | -268.72 | -177.58 | -368.51 |
| % Growth | 71.2% | -51.3% | 51.8% | – |
| Operating Cash Flow | -$2,359 | -$5,713 | -$2,231 | -$14,787 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,359 | -$5,713 | -$2,231 | -$14,787 |